Non-Clinical Studies and Laboratory Support IDIQ_Amendment2

Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
State: Maryland
Type of Government: Federal
FSC Category:
  • B - Special Studies and Analyses - Not R&D
NAICS Category:
  • 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Posted Date: Mar 30, 2023
Due Date: Apr 5, 2023
Solicitation No: FDA-RFP-75F40122R00067_Amendment2
Bid Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page
Follow
Non-Clinical Studies and Laboratory Support IDIQ_Amendment2
Active
Contract Opportunity
Notice ID
FDA-RFP-75F40122R00067_Amendment2
Related Notice
FDA-RFI-1249946
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
FOOD AND DRUG ADMINISTRATION
Office
FDA OFFICE OF ACQ GRANT SVCS
Looking for contract opportunity help?

Procurement Technical Assistance Centers (PTACs) are an official government contracting resource for small businesses. Find your local PTAC (opens in new window) for free government expertise related to contract opportunities.

General Information View Changes
  • Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
  • All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
  • Updated Published Date: Mar 30, 2023 05:06 pm EDT
  • Original Published Date: Mar 16, 2023 04:09 pm EDT
  • Updated Date Offers Due: Apr 05, 2023 05:30 pm EDT
  • Original Date Offers Due: Apr 05, 2023 05:30 pm EDT
  • Inactive Policy: 15 days after date offers due
  • Updated Inactive Date: Apr 20, 2023
  • Original Inactive Date: Apr 20, 2023
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: B529 - SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA
  • NAICS Code:
    • 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  • Place of Performance:
    Silver Spring , MD 20993
    USA
Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with (IAW) the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This is a request for proposal (RFP) for commercial items IAW the procedures of FAR Part 12 – Acquisition of Commercial Items, in conjunction with FAR Part 15 – Contracting by Negotiation. This acquisition is issued as a Request for Proposal (RFP).



This solicitation document incorporates provisions and clauses in effect through Federal Acquisition Circular FAC 2023-01, effective December 30, 2022.



All questions regarding this solicitation, of a contractual nature or technical nature, shall be submitted in writing and sent via email to the Contract Specialist (Nikola.Zuber@fda.hhs.gov), by no later than 12:00 PM Eastern Time, on 3/23/2023. The Government may not consider questions received after this date and time. The email subject line shall read: FDA-RFP-75F40122R00067. It is the Offeror’s responsibility to confirm receipt of all proposals and/or questions by the closing date of this announcement by contacting the above Contract Specialist/Contracting Officer.



It is the FDA’s intent to award an indefinite delivery-indefinite quantity (IDIQ) contract, with a performance period of five (5) years. The Government anticipates awarding an single award IDIQ contract with a ceiling of $20,000,000.00. These is no minimum or maximum number of delivery orders/task orders set for this IDIQ.



IDIQ Minimum: The minimum guarantee for this IDIQ contract is $2,500.00, which will be obligated through a separate Task Order following the IDIQ award.



IDIQ Maximum: The maximum aggregate dollar value of all task orders awarded over the 5-year ordering period of this IDIQ shall not exceed the IDIQ ceiling amount of $20,000,000.00.



It is anticipated that a single-award Indefinite Delivery-Indefinite Quantity (IDIQ) type Contract, per FAR 16.5, will be awarded as a result of this solicitation. Authorized contract types under this IDIQ contract are: Labor-Hour (LH), Time-and-Materials (T&M), Firm-Fixed-Price (FFP) or a combination thereof.



See attached documentation for all information regarding this combined synopsis/solicitation posting.






Attachments/Links
Contact Information
Contracting Office Address
  • 4041 Powder Mill Road 4th Floor
  • Beltsville , MD 20705
  • USA
Primary Point of Contact
Secondary Point of Contact
History

Related Document

Mar 17, 2023[Combined Synopsis/Solicitation (Original)] Non-Clinical Studies and Laboratory Support IDIQ_Amendment2

Sign-up for a Free Trial, Government Bid Alerts

With Free Trial, you can:

You will have a full access to bids, website, and receive daily bid report via email and web.

Try One Week FREE Now

See Also

Follow 1305M224R0017 - Analytical Chemistry Services, Sediment Analysis Active Contract Opportunity Notice ID

COMMERCE, DEPARTMENT OF

Bid Due: 4/26/2024

Bid Opportunity Detail Return to Listing Supplier Registration Bid Information Type Request for

City of Frederick

Bid Due: 5/15/2024

Editing column ID Title Status Due / Close Date Publish Date Main Category

State Government of Maryland

Bid Due: 4/30/2024

Editing column ID Title Status Due / Close Date Publish Date Main Category

State Government of Maryland

Bid Due: 5/22/2024